Evidence map›Paper›PMID 24667435›Full record

ArticlePloS one2014

Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy.

Angelica Vaccaro, Fabien Despas, Clement Delmas, Olivier Lairez, Elisabeth Lambert, Gavin Lambert, Marc Labrunee, Thibaut Guiraud, Murray Esler, Michel Galinier and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04695587 (The Role of Sympathetic Tone Regarding the Anatomical and Functional Recovery of the Left Ventricle in TakoTsubo Syndrome), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04695587 unknown statusnot on this mapstarted 2019, after this paper: background citation

The Role of Sympathetic Tone Regarding the Anatomical and Functional Recovery of the Left Ventricle in TakoTsubo Syndrome

TypeobservationalSponsorHippocration General HospitalRan2019 to 2023Enrolled30ConditionsTakotsubo CardiomyopathyArms123 MIBG scintigraphy testing, MSNA, ABPM, ECHO, 24hour ECG
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. The role of central autonomic nervous system dysfunction in Takotsubo syndrome: a systematic review.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2022
    Pooled it
  2. Sympathetic nerve activity and response to physiological stress in Takotsubo syndrome.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Trial
  3. Review
  4. Review
  5. Article
  6. Takotsubo syndrome: Unraveling the mystery behind its triggers (Review).International journal of molecular medicine · 2025
    Review
  7. Article
  8. Takotsubo syndrome linked to paroxysmal sympathetic hyperactivity as a postoperative complication after brain tumor removal: a case report and literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Autonomic control of ventricular function in health and disease: current state of the art.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2023
    Review
  13. Review
  14. Update of Takotsubo cardiomyopathy: Present experience and outlook for the future.International journal of cardiology. Heart & vasculature · 2022
    Review
  15. Metabolic remodeling in takotsubo syndrome.Frontiers in cardiovascular medicine · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Angelica VaccaroNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; C.I.C., Clinical Investigation Center, University Hospital of Toulouse, Toulouse, France.
Fabien DespasNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Toulouse University III Paul Sabatier, Toulouse, France; Clinical Pharmacology Department, University Hospital of Toulouse, Toulouse, France.
Clement DelmasNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Department of Cardiology, University Hospital of Toulouse, Toulouse, France.
Olivier LairezNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Toulouse University III Paul Sabatier, Toulouse, France; Department of Cardiology, University Hospital of Toulouse, Toulouse, France.
Elisabeth LambertHuman Neurotransmitter Laboratory, Baker IDI Heart and Diabetes Institute and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Gavin LambertHuman Neurotransmitter Laboratory, Baker IDI Heart and Diabetes Institute and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Marc LabruneeNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Toulouse University III Paul Sabatier, Toulouse, France; Department of Cardiology, University Hospital of Toulouse, Toulouse, France.
Thibaut GuiraudNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Toulouse University III Paul Sabatier, Toulouse, France.
Murray EslerHuman Neurotransmitter Laboratory, Baker IDI Heart and Diabetes Institute and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Michel GalinierNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Toulouse University III Paul Sabatier, Toulouse, France; Department of Cardiology, University Hospital of Toulouse, Toulouse, France.
Jean Michel SenardNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Toulouse University III Paul Sabatier, Toulouse, France; Clinical Pharmacology Department, University Hospital of Toulouse, Toulouse, France; Department of Cardiology, University Hospital of Toulouse, Toulouse, France.
Atul PathakNational Institute of Health and Medical Research (INSERM) UMR-1048, Institute of Metabolic and Cardiovascular diseases, Toulouse, France; Toulouse University III Paul Sabatier, Toulouse, France; Clinical Pharmacology Department, University Hospital of Toulouse, Toulouse, France; Department of Cardiology, University Hospital of Toulouse, Toulouse, France; Human Neurotransmitter Laboratory, Baker IDI Heart and Diabetes Institute and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia; C.I.C., Clinical Investigation Center, University Hospital of Toulouse, Toulouse, France.
Université Fédérale de Toulouse Midi-Pyrénées · FRBaker Heart and Diabetes Institute · AUUniversité Toulouse III - Paul Sabatier · FRInserm · FRInstitut des Maladies Métaboliques et Cardiovasculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe exact pathophysiology of Tako-Tsubo cardiomyopathy (TTC) remains unknown but a role for sympathetic hyperactivity has been suggested. Up to now, no direct evidence of sympathetic nerve hyperactivity has been established nor involvement of sympathetic baroreflex identified. The aim of our study was to determine, by direct sympathetic nerve activity (SNS) recording if sympathetic nervous system activity is increased and spontaneous baroreflex control of sympathetic activity reduced in patients with TTC.

methodsWe included 13 patients who presented with TTC and compared their SNS activity and spontaneous baroreflex control of sympathetic activity with that of 13 control patients with acutely decompensated chronic heart failure. SNS activity was evaluated by microneurography, a technique assessing muscle sympathetic nerve activity (MSNA). Spontaneous baroreflex control of sympathetic activity was evaluated as the absolute value of the slope of the regression line representing the relationship between spontaneous diastolic blood pressure values and concomitant SNS activity. Control patients were matched for age, sex, left ventricular ejection fraction and creatinine clearance.

resultsThe mean age of the patients with TTC was 80 years, all patients were women. There were no significant differences between the two groups of patients for blood pressure, heart rate or oxygen saturation level. TTC patients presented a significant increase in sympathetic nerve activity (MSNA median 63.3 bursts/min [interquartile range 61.3 to 66.0] vs median 55.7 bursts/min [interquartile range 51.0 to 61.7]; p = 0.0089) and a decrease in spontaneous baroreflex control of sympathetic activity compared to matched control patients (spontaneous baroreflex control of sympathetic activity median 0.7%burst/mmHg [interquartile range 0.4 to 1.9] vs median 2.4%burst/mmHg [interquartile range 1.8 to 2.9]; p = 0.005).

conclusionsWe report for the first time, through direct measurement of sympathetic nerve activity, that patients with TTC exhibit elevated SNS activity associated with a decrease in spontaneous baroreflex control of sympathetic activity. These data may explain the pathophysiology and clinical presentation of patient with TTC.

Indexed as

BaroreflexAged, 80 and overBlood PressureCase-Control StudiesFemaleHeart RateHumansMaleMiddle AgedMusclesSympathetic Nervous SystemTakotsubo Cardiomyopathy

Identifiers

PMID24667435
PMCPMC3965544
OpenAlexW1996476986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.